A generic and inexpensive way to seperate chiral molecules: magnets

Will President Trump’s prices plan deliver for Americans patients?

Pharma TV ads are getting longer, less humorous and more nostalgic — while containing fewer facts.

Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?

Concerns abound that post-Brexit border delays could turn the UK into a “second tier state for pharmaceutical imports.”

Regulators step in to stop stem cell clinics from marketing unproven therapies.

The cell therapy industry faces a number of complex problems. Fortunately, they’re good problems to have.

Are pharma companies ready for the upcoming serialization deadlines?

Could NIR CI offer improved monitoring of tablet manufacture?

Airfreight or sea cargo: the verdict.